NURIX THERAPEUTICS, INC. (NRIX) /
The debt of NURIX THERAPEUTICS, INC. over the past 7 years
Chart NURIX THERAPEUTICS, INC.: liquid cash, total debt, net cash, fiscal 2019–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, NURIX THERAPEUTICS, INC. had liquid cash of $592.94M and total debt of $0: net cash of $592.94M. It had more liquid cash than debt at all 7 year-ends shown.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Nov 30, 2025 | $592.94M* | $0 | $592.94M |
| 2024ended Nov 30, 2024 | $609.58M* | $0 | $609.58M |
| 2023ended Nov 30, 2023 | $287.91M* | $0 | $287.91M |
| 2022ended Nov 30, 2022 | $309.14M* | $0 | $309.14M |
| 2021ended Nov 30, 2021 | $295.72M* | $0 | $295.72M |
| 2020ended Nov 30, 2020 | $281.15M* | $0 | $281.15M |
| 2019ended Nov 30, 2019 | $37.72M* | $0 | $37.72M |
Fiscal years as NURIX THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on NURIX THERAPEUTICS, INC.
- The revenue of NURIX THERAPEUTICS, INC.
- The profitability of NURIX THERAPEUTICS, INC.
- The cash flow of NURIX THERAPEUTICS, INC.
- All of NURIX THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- UNFIUnited Natural Foods, Inc.
- DANDana Incorporated
- FLYFirefly Aerospace Inc.
- PTRNPattern Group Inc.
- CUBICustomers Bancorp, Inc.
Not investment advice. This page shows what NURIX THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.